NCT06855251 SENSing Inner BodiLy State: Understanding the Role of Interoception in obEsity
| NCT ID | NCT06855251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Auxologico Italiano |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 32 participants in total. It began in 2024-04-01 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Successfully perceiving the flow of interoceptive cues and integrating them with exteroceptive information are fundamental aspects of countering the body's inherent instability and guaranteeing homeostatic regulation. This process deeply affects cognitive/emotional functioning and general health. Recently, it has been suggested that an important signature underpinning obesity might be an interoceptive dysfunction in perceiving internal body signals and/or integrating them with information from the external environment. There is evidence that interoceptive deficits correlate with Body Mass Index (BMI), but it is still largely unclear how different measures and facets of interoception are related to high BMI and eating behaviour. Within this framework, it is mandatory to understand the role of interoception in obesity at perceptual, cognitive, and emotional levels. One open issue regards the relationships between interoceptive signals and the reactivity to external food cues.
Eligibility Criteria
Inclusion Criteria: * Right-handed individuals diagnosed with obesity * In rehabilitative treatment at the Istituto Auxologico Exclusion Criteria: * Concurrent neurological, neurodevelopmental (e.g., autism), motor, somatosensory and/or psychiatric disorders
Contact & Investigator
Federica Scarpina, PhD
PRINCIPAL INVESTIGATOR
IRCCS Istituto Auxologico Italiano
Frequently Asked Questions
Who can join the NCT06855251 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06855251 currently recruiting?
Yes, NCT06855251 is actively recruiting participants. Contact the research team at f.scarpina@auxologico.it for enrollment information.
Where is the NCT06855251 trial being conducted?
This trial is being conducted at Piancavallo, Italy.
Who is sponsoring the NCT06855251 clinical trial?
NCT06855251 is sponsored by Istituto Auxologico Italiano. The principal investigator is Federica Scarpina, PhD at IRCCS Istituto Auxologico Italiano. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.